

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | actin-myosin filament sliding (GO:0033275) | 6.73284077 |
| 2 | muscle filament sliding (GO:0030049) | 6.73284077 |
| 3 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 6.63251326 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.44060471 |
| 5 | L-phenylalanine catabolic process (GO:0006559) | 6.44060471 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.28960612 |
| 7 | L-phenylalanine metabolic process (GO:0006558) | 6.28960612 |
| 8 | regulation of skeletal muscle contraction (GO:0014819) | 5.98193934 |
| 9 | aromatic amino acid family catabolic process (GO:0009074) | 5.66960106 |
| 10 | skeletal muscle contraction (GO:0003009) | 5.41967119 |
| 11 | actin-mediated cell contraction (GO:0070252) | 5.38638861 |
| 12 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.33856472 |
| 13 | kynurenine metabolic process (GO:0070189) | 5.33598438 |
| 14 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.31696230 |
| 15 | alpha-linolenic acid metabolic process (GO:0036109) | 5.24221587 |
| 16 | glyoxylate metabolic process (GO:0046487) | 5.21439069 |
| 17 | lysine metabolic process (GO:0006553) | 5.11147370 |
| 18 | lysine catabolic process (GO:0006554) | 5.11147370 |
| 19 | indole-containing compound catabolic process (GO:0042436) | 5.01627518 |
| 20 | indolalkylamine catabolic process (GO:0046218) | 5.01627518 |
| 21 | tryptophan catabolic process (GO:0006569) | 5.01627518 |
| 22 | bile acid biosynthetic process (GO:0006699) | 4.95900760 |
| 23 | sulfur amino acid catabolic process (GO:0000098) | 4.84241965 |
| 24 | creatine metabolic process (GO:0006600) | 4.72490300 |
| 25 | cysteine metabolic process (GO:0006534) | 4.69862971 |
| 26 | tryptophan metabolic process (GO:0006568) | 4.68880994 |
| 27 | urea metabolic process (GO:0019627) | 4.67733373 |
| 28 | urea cycle (GO:0000050) | 4.67733373 |
| 29 | negative regulation of fibrinolysis (GO:0051918) | 4.67278465 |
| 30 | complement activation, alternative pathway (GO:0006957) | 4.63237851 |
| 31 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.61394403 |
| 32 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.59098914 |
| 33 | protein carboxylation (GO:0018214) | 4.59098914 |
| 34 | regulation of cholesterol esterification (GO:0010872) | 4.56127526 |
| 35 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.55211861 |
| 36 | synaptic vesicle maturation (GO:0016188) | 4.49800404 |
| 37 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.47542524 |
| 38 | cellular ketone body metabolic process (GO:0046950) | 4.46745827 |
| 39 | high-density lipoprotein particle remodeling (GO:0034375) | 4.40970776 |
| 40 | regulation of protein activation cascade (GO:2000257) | 4.40158565 |
| 41 | striated muscle contraction (GO:0006941) | 4.38222764 |
| 42 | skeletal muscle fiber development (GO:0048741) | 4.38076488 |
| 43 | regulation of fibrinolysis (GO:0051917) | 4.37897532 |
| 44 | neuronal action potential propagation (GO:0019227) | 4.36340341 |
| 45 | serine family amino acid catabolic process (GO:0009071) | 4.36200269 |
| 46 | regulation of triglyceride catabolic process (GO:0010896) | 4.29595563 |
| 47 | nitrogen cycle metabolic process (GO:0071941) | 4.28993838 |
| 48 | homocysteine metabolic process (GO:0050667) | 4.25920883 |
| 49 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.22601886 |
| 50 | bile acid metabolic process (GO:0008206) | 4.18038425 |
| 51 | amino-acid betaine metabolic process (GO:0006577) | 4.16889342 |
| 52 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.16860636 |
| 53 | 2-oxoglutarate metabolic process (GO:0006103) | 4.14141304 |
| 54 | regulation of complement activation (GO:0030449) | 4.13185953 |
| 55 | myotube cell development (GO:0014904) | 4.11700313 |
| 56 | alpha-amino acid catabolic process (GO:1901606) | 4.11033537 |
| 57 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 4.08085031 |
| 58 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 4.08085031 |
| 59 | acylglycerol homeostasis (GO:0055090) | 4.07005738 |
| 60 | triglyceride homeostasis (GO:0070328) | 4.07005738 |
| 61 | aromatic amino acid family metabolic process (GO:0009072) | 4.05387394 |
| 62 | glutamate metabolic process (GO:0006536) | 4.03526263 |
| 63 | aspartate family amino acid catabolic process (GO:0009068) | 3.98570101 |
| 64 | acetyl-CoA metabolic process (GO:0006084) | 3.97984788 |
| 65 | plasma lipoprotein particle clearance (GO:0034381) | 3.93439112 |
| 66 | coenzyme catabolic process (GO:0009109) | 3.93048705 |
| 67 | cellular modified amino acid catabolic process (GO:0042219) | 3.91944068 |
| 68 | tyrosine metabolic process (GO:0006570) | 3.87518547 |
| 69 | cellular amino acid catabolic process (GO:0009063) | 3.87013009 |
| 70 | reverse cholesterol transport (GO:0043691) | 3.86768404 |
| 71 | regulation of cholesterol homeostasis (GO:2000188) | 3.85273547 |
| 72 | ketone body metabolic process (GO:1902224) | 3.84600131 |
| 73 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.84323445 |
| 74 | actin filament-based movement (GO:0030048) | 3.84203142 |
| 75 | negative regulation of sterol transport (GO:0032372) | 3.82903832 |
| 76 | negative regulation of cholesterol transport (GO:0032375) | 3.82903832 |
| 77 | plasma lipoprotein particle remodeling (GO:0034369) | 3.79763031 |
| 78 | protein-lipid complex remodeling (GO:0034368) | 3.79763031 |
| 79 | macromolecular complex remodeling (GO:0034367) | 3.79763031 |
| 80 | short-chain fatty acid metabolic process (GO:0046459) | 3.79730669 |
| 81 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.75253019 |
| 82 | positive regulation of lipid catabolic process (GO:0050996) | 3.72766062 |
| 83 | fatty acid beta-oxidation (GO:0006635) | 3.72461563 |
| 84 | regulation of relaxation of muscle (GO:1901077) | 3.72318491 |
| 85 | ethanol oxidation (GO:0006069) | 3.72071184 |
| 86 | fatty acid transmembrane transport (GO:1902001) | 3.70582677 |
| 87 | phospholipid homeostasis (GO:0055091) | 3.70557893 |
| 88 | myofibril assembly (GO:0030239) | 3.70057013 |
| 89 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.69406796 |
| 90 | cardiac muscle contraction (GO:0060048) | 3.63939237 |
| 91 | response to inactivity (GO:0014854) | 3.62399815 |
| 92 | phospholipid efflux (GO:0033700) | 3.61854026 |
| 93 | synaptic vesicle exocytosis (GO:0016079) | 3.59533247 |
| 94 | bile acid and bile salt transport (GO:0015721) | 3.56708228 |
| 95 | fatty acid oxidation (GO:0019395) | 3.56180733 |
| 96 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.53793291 |
| 97 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.52412134 |
| 98 | lipid oxidation (GO:0034440) | 3.49503715 |
| 99 | monocarboxylic acid catabolic process (GO:0072329) | 3.48269572 |
| 100 | fatty acid catabolic process (GO:0009062) | 3.48199863 |
| 101 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.47421802 |
| 102 | carboxylic acid catabolic process (GO:0046395) | 3.47260047 |
| 103 | organic acid catabolic process (GO:0016054) | 3.47260047 |
| 104 | indolalkylamine metabolic process (GO:0006586) | 3.44699541 |
| 105 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.44320720 |
| 106 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.44229545 |
| 107 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.44229545 |
| 108 | benzene-containing compound metabolic process (GO:0042537) | 3.44188576 |
| 109 | carnitine shuttle (GO:0006853) | 3.43793953 |
| 110 | glycine metabolic process (GO:0006544) | 3.42369413 |
| 111 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.41360612 |
| 112 | drug catabolic process (GO:0042737) | 3.40756022 |
| 113 | valine metabolic process (GO:0006573) | 3.38752583 |
| 114 | establishment of mitochondrion localization (GO:0051654) | 3.38575301 |
| 115 | serine family amino acid metabolic process (GO:0009069) | 3.38469307 |
| 116 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.37712338 |
| 117 | muscle contraction (GO:0006936) | 3.33131945 |
| 118 | cholesterol homeostasis (GO:0042632) | 3.32806899 |
| 119 | cholesterol efflux (GO:0033344) | 3.32165683 |
| 120 | sarcomere organization (GO:0045214) | 3.31668468 |
| 121 | arginine metabolic process (GO:0006525) | 3.30965605 |
| 122 | positive regulation of fatty acid oxidation (GO:0046321) | 3.30941383 |
| 123 | cellular glucuronidation (GO:0052695) | 3.30241764 |
| 124 | sterol homeostasis (GO:0055092) | 3.28589844 |
| 125 | carnitine metabolic process (GO:0009437) | 3.25904719 |
| 126 | fibrinolysis (GO:0042730) | 3.24192674 |
| 127 | amine catabolic process (GO:0009310) | 3.23415254 |
| 128 | cellular biogenic amine catabolic process (GO:0042402) | 3.23415254 |
| 129 | cytolysis (GO:0019835) | 3.22337373 |
| 130 | muscle fiber development (GO:0048747) | 3.18699507 |
| 131 | negative regulation of lipase activity (GO:0060192) | 3.16374050 |
| 132 | drug transmembrane transport (GO:0006855) | 3.15445129 |
| 133 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.14542944 |
| 134 | plasma lipoprotein particle assembly (GO:0034377) | 3.14517911 |
| 135 | skeletal muscle tissue regeneration (GO:0043403) | 3.14280439 |
| 136 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 3.13456156 |
| 137 | cofactor catabolic process (GO:0051187) | 3.13355184 |
| 138 | glutamate secretion (GO:0014047) | 3.11713182 |
| 139 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.11508693 |
| 140 | exogenous drug catabolic process (GO:0042738) | 3.11157426 |
| 141 | imidazole-containing compound metabolic process (GO:0052803) | 3.10476496 |
| 142 | regulation of bile acid biosynthetic process (GO:0070857) | 3.09906287 |
| 143 | negative regulation of protein localization to cell surface (GO:2000009) | 3.09287214 |
| 144 | regulation of synapse structural plasticity (GO:0051823) | 3.09275000 |
| 145 | adenosine receptor signaling pathway (GO:0001973) | 3.08634174 |
| 146 | neuromuscular synaptic transmission (GO:0007274) | 3.07108503 |
| 147 | regulation of synaptic vesicle transport (GO:1902803) | 3.06647272 |
| 148 | muscle system process (GO:0003012) | 3.02349417 |
| 149 | response to muscle activity (GO:0014850) | 3.00231360 |
| 150 | cardiac myofibril assembly (GO:0055003) | 2.97554508 |
| 151 | activation of protein kinase A activity (GO:0034199) | 2.95568016 |
| 152 | glycogen catabolic process (GO:0005980) | 2.93266944 |
| 153 | positive regulation of synapse maturation (GO:0090129) | 2.90585216 |
| 154 | membrane depolarization during action potential (GO:0086010) | 2.88455318 |
| 155 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.87617606 |
| 156 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.87323701 |
| 157 | regulation of cell communication by electrical coupling (GO:0010649) | 2.86346232 |
| 158 | mitochondrion transport along microtubule (GO:0047497) | 2.85679384 |
| 159 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.85679384 |
| 160 | postsynaptic membrane organization (GO:0001941) | 2.82346073 |
| 161 | negative regulation of cation channel activity (GO:2001258) | 2.81510020 |
| 162 | negative regulation of heart rate (GO:0010459) | 2.80622814 |
| 163 | positive regulation of myotube differentiation (GO:0010831) | 2.77527854 |
| 164 | neuronal ion channel clustering (GO:0045161) | 2.77220472 |
| 165 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.76460913 |
| 166 | regulation of actin filament-based movement (GO:1903115) | 2.76431534 |
| 167 | negative regulation of muscle contraction (GO:0045932) | 2.75954787 |
| 168 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.75469450 |
| 169 | negative regulation of heart contraction (GO:0045822) | 2.73021171 |
| 170 | negative regulation of appetite (GO:0032099) | 2.71990613 |
| 171 | negative regulation of response to food (GO:0032096) | 2.71990613 |
| 172 | heart process (GO:0003015) | 2.68993227 |
| 173 | heart contraction (GO:0060047) | 2.68993227 |
| 174 | regulation of platelet aggregation (GO:0090330) | 2.68557554 |
| 175 | cardiac muscle hypertrophy (GO:0003300) | 2.67982574 |
| 176 | synaptic vesicle endocytosis (GO:0048488) | 2.67963291 |
| 177 | regulation of striated muscle contraction (GO:0006942) | 2.64432250 |
| 178 | protein insertion into membrane (GO:0051205) | 2.62821579 |
| 179 | striated muscle hypertrophy (GO:0014897) | 2.62126979 |
| 180 | muscle cell cellular homeostasis (GO:0046716) | 2.61638553 |
| 181 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.61616717 |
| 182 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.60654632 |
| 183 | glucan catabolic process (GO:0009251) | 2.60459153 |
| 184 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.59512904 |
| 185 | negative regulation of blood circulation (GO:1903523) | 2.59437572 |
| 186 | regulation of membrane repolarization (GO:0060306) | 2.59281108 |
| 187 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.58590227 |
| 188 | glycolytic process (GO:0006096) | 2.54626025 |
| 189 | gluconeogenesis (GO:0006094) | 2.54409399 |
| 190 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.53600827 |
| 191 | synaptic transmission, glutamatergic (GO:0035249) | 2.53326765 |
| 192 | neurotransmitter secretion (GO:0007269) | 2.51398390 |
| 193 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.51085088 |
| 194 | relaxation of muscle (GO:0090075) | 2.49787130 |
| 195 | regulation of cation channel activity (GO:2001257) | 2.49536785 |
| 196 | cellular polysaccharide catabolic process (GO:0044247) | 2.48884641 |
| 197 | regulation of synapse maturation (GO:0090128) | 2.48737814 |
| 198 | dopamine transport (GO:0015872) | 2.48291271 |
| 199 | skeletal muscle tissue development (GO:0007519) | 2.46945518 |
| 200 | muscle hypertrophy (GO:0014896) | 2.46574402 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.49240632 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.67181327 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.40574253 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.84755883 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.50835281 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.29467423 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.39543188 |
| 8 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.34032449 |
| 9 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.70570414 |
| 10 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 3.31062464 |
| 11 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.11213984 |
| 12 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.59140655 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.58036083 |
| 14 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.45200462 |
| 15 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.23436624 |
| 16 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.19702851 |
| 17 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.04642123 |
| 18 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.02473757 |
| 19 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.02000151 |
| 20 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.96638258 |
| 21 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.96628553 |
| 22 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.94711679 |
| 23 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.93304625 |
| 24 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.89412110 |
| 25 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.86722949 |
| 26 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.82604358 |
| 27 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.80346301 |
| 28 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.79932261 |
| 29 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.79797530 |
| 30 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.72701603 |
| 31 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.70908645 |
| 32 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.69214279 |
| 33 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.66938805 |
| 34 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.66417102 |
| 35 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.61472069 |
| 36 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.58317139 |
| 37 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.57480270 |
| 38 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56323614 |
| 39 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.53619553 |
| 40 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.52703707 |
| 41 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.52155846 |
| 42 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.49261490 |
| 43 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.47901436 |
| 44 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.45356924 |
| 45 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.44615018 |
| 46 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.44118212 |
| 47 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.43043957 |
| 48 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.42944542 |
| 49 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.42944542 |
| 50 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.41915386 |
| 51 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.40201832 |
| 52 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.40061879 |
| 53 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.36698711 |
| 54 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.33438621 |
| 55 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.29574330 |
| 56 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.29517317 |
| 57 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.29206742 |
| 58 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.24910031 |
| 59 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.23867529 |
| 60 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.23152727 |
| 61 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.22876616 |
| 62 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21709937 |
| 63 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.20270202 |
| 64 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.20242779 |
| 65 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.19425179 |
| 66 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.19420229 |
| 67 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.18095859 |
| 68 | * MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.16944077 |
| 69 | GATA1_22025678_ChIP-Seq_K562_Human | 1.15777237 |
| 70 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.13981684 |
| 71 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.12970649 |
| 72 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.12958711 |
| 73 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.12927962 |
| 74 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10735354 |
| 75 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.09961763 |
| 76 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.09019739 |
| 77 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.07791517 |
| 78 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.07791517 |
| 79 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.06128823 |
| 80 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.05874287 |
| 81 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.04867409 |
| 82 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.04412151 |
| 83 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.03958829 |
| 84 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.02954017 |
| 85 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.02450005 |
| 86 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.01467710 |
| 87 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.01268332 |
| 88 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.99947554 |
| 89 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.99666299 |
| 90 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.99366654 |
| 91 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.98794997 |
| 92 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.97513231 |
| 93 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.97419115 |
| 94 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.97383438 |
| 95 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.95368822 |
| 96 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.93950817 |
| 97 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93124983 |
| 98 | * SPI1_23127762_ChIP-Seq_K562_Human | 0.93038502 |
| 99 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.92893115 |
| 100 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.92424233 |
| 101 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.92305375 |
| 102 | * NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.91758516 |
| 103 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.90948626 |
| 104 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.89756787 |
| 105 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.88806255 |
| 106 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.86441714 |
| 107 | GATA1_19941826_ChIP-Seq_K562_Human | 0.85595310 |
| 108 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.84483385 |
| 109 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.83835378 |
| 110 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.83594936 |
| 111 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.82300730 |
| 112 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.81904812 |
| 113 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.81070288 |
| 114 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.80843976 |
| 115 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.80564038 |
| 116 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.80524319 |
| 117 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.80491475 |
| 118 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.79891974 |
| 119 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.79849742 |
| 120 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.78559944 |
| 121 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.78549389 |
| 122 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.77934504 |
| 123 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.77801515 |
| 124 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.76983272 |
| 125 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.76434965 |
| 126 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.76164097 |
| 127 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.75974788 |
| 128 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.75691375 |
| 129 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.75548820 |
| 130 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.73501356 |
| 131 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.73289665 |
| 132 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.72534748 |
| 133 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.72522513 |
| 134 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.72405537 |
| 135 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.71298673 |
| 136 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.71103415 |
| 137 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.70618525 |
| 138 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.68582584 |
| 139 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.68380828 |
| 140 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.68369468 |
| 141 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.68091272 |
| 142 | * P68_20966046_ChIP-Seq_HELA_Human | 0.68065908 |
| 143 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.67833940 |
| 144 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.67554421 |
| 145 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.67234707 |
| 146 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.66389106 |
| 147 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.66389106 |
| 148 | GATA2_19941826_ChIP-Seq_K562_Human | 0.65918780 |
| 149 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.65569291 |
| 150 | * SMC4_20622854_ChIP-Seq_HELA_Human | 0.64758552 |
| 151 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.64382562 |
| 152 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.64188646 |
| 153 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.63599518 |
| 154 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.63335405 |
| 155 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.63060504 |
| 156 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.61166046 |
| 157 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.61076265 |
| 158 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.60503044 |
| 159 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.59162710 |
| 160 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.58409567 |
| 161 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.57972569 |
| 162 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.57533504 |
| 163 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.57265519 |
| 164 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.57038794 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.11796681 |
| 2 | MP0005360_urolithiasis | 6.41544925 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.50990119 |
| 4 | MP0005365_abnormal_bile_salt | 5.23507670 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.02953475 |
| 6 | MP0004859_abnormal_synaptic_plasticity | 3.86640251 |
| 7 | MP0003252_abnormal_bile_duct | 3.50297734 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 3.40545088 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.23455330 |
| 10 | MP0009840_abnormal_foam_cell | 3.21625691 |
| 11 | MP0005083_abnormal_biliary_tract | 3.01232083 |
| 12 | MP0005464_abnormal_platelet_physiology | 2.77891537 |
| 13 | MP0005332_abnormal_amino_acid | 2.73486357 |
| 14 | MP0004270_analgesia | 2.60218066 |
| 15 | MP0003195_calcinosis | 2.59821118 |
| 16 | MP0002837_dystrophic_cardiac_calcinosis | 2.40335177 |
| 17 | MP0005423_abnormal_somatic_nervous | 2.26914415 |
| 18 | MP0001666_abnormal_nutrient_absorption | 2.23138984 |
| 19 | MP0003191_abnormal_cellular_cholesterol | 2.21833151 |
| 20 | MP0005369_muscle_phenotype | 2.12443236 |
| 21 | MP0002118_abnormal_lipid_homeostasis | 2.10511737 |
| 22 | MP0003705_abnormal_hypodermis_morpholog | 2.05730181 |
| 23 | MP0003635_abnormal_synaptic_transmissio | 2.03773174 |
| 24 | MP0000609_abnormal_liver_physiology | 1.96012948 |
| 25 | MP0004130_abnormal_muscle_cell | 1.95037416 |
| 26 | MP0002138_abnormal_hepatobiliary_system | 1.90345346 |
| 27 | MP0005319_abnormal_enzyme/_coenzyme | 1.78108749 |
| 28 | MP0004233_abnormal_muscle_weight | 1.75067803 |
| 29 | MP0003646_muscle_fatigue | 1.74695364 |
| 30 | MP0004019_abnormal_vitamin_homeostasis | 1.73608690 |
| 31 | MP0003880_abnormal_central_pattern | 1.64026139 |
| 32 | MP0002063_abnormal_learning/memory/cond | 1.62875714 |
| 33 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.59385515 |
| 34 | MP0001529_abnormal_vocalization | 1.57931921 |
| 35 | MP0008569_lethality_at_weaning | 1.57622626 |
| 36 | MP0009046_muscle_twitch | 1.54503859 |
| 37 | MP0002733_abnormal_thermal_nociception | 1.52628337 |
| 38 | MP0006276_abnormal_autonomic_nervous | 1.52483705 |
| 39 | MP0002064_seizures | 1.52417025 |
| 40 | MP0001905_abnormal_dopamine_level | 1.46015353 |
| 41 | MP0005670_abnormal_white_adipose | 1.45612331 |
| 42 | MP0003879_abnormal_hair_cell | 1.43298455 |
| 43 | MP0000733_abnormal_muscle_development | 1.41914591 |
| 44 | MP0003868_abnormal_feces_composition | 1.39653662 |
| 45 | MP0009745_abnormal_behavioral_response | 1.37986289 |
| 46 | MP0002735_abnormal_chemical_nociception | 1.36967391 |
| 47 | MP0009643_abnormal_urine_homeostasis | 1.34279037 |
| 48 | MP0002734_abnormal_mechanical_nocicepti | 1.32810795 |
| 49 | MP0002572_abnormal_emotion/affect_behav | 1.32791709 |
| 50 | MP0001968_abnormal_touch/_nociception | 1.30679294 |
| 51 | MP0005666_abnormal_adipose_tissue | 1.28765478 |
| 52 | MP0000751_myopathy | 1.26275530 |
| 53 | MP0001970_abnormal_pain_threshold | 1.25113383 |
| 54 | MP0002272_abnormal_nervous_system | 1.22523814 |
| 55 | MP0000604_amyloidosis | 1.19730804 |
| 56 | MP0005451_abnormal_body_composition | 1.18440247 |
| 57 | MP0001486_abnormal_startle_reflex | 1.17214789 |
| 58 | MP0006036_abnormal_mitochondrial_physio | 1.17101705 |
| 59 | MP0004142_abnormal_muscle_tone | 1.16925025 |
| 60 | MP0004811_abnormal_neuron_physiology | 1.16881476 |
| 61 | MP0004036_abnormal_muscle_relaxation | 1.14350541 |
| 62 | MP0008004_abnormal_stomach_pH | 1.13497880 |
| 63 | MP0002971_abnormal_brown_adipose | 1.12683951 |
| 64 | MP0005410_abnormal_fertilization | 1.12533286 |
| 65 | MP0004484_altered_response_of | 1.10580901 |
| 66 | MP0005330_cardiomyopathy | 1.08863793 |
| 67 | MP0002269_muscular_atrophy | 1.08343300 |
| 68 | MP0002067_abnormal_sensory_capabilities | 1.08088454 |
| 69 | MP0000749_muscle_degeneration | 1.07028510 |
| 70 | MP0003656_abnormal_erythrocyte_physiolo | 1.05057832 |
| 71 | MP0003329_amyloid_beta_deposits | 1.04562442 |
| 72 | MP0002078_abnormal_glucose_homeostasis | 1.02638907 |
| 73 | MP0000013_abnormal_adipose_tissue | 1.01744750 |
| 74 | MP0005535_abnormal_body_temperature | 1.01182017 |
| 75 | MP0000598_abnormal_liver_morphology | 1.00131838 |
| 76 | MP0001764_abnormal_homeostasis | 0.99485306 |
| 77 | MP0004084_abnormal_cardiac_muscle | 0.98600582 |
| 78 | MP0004087_abnormal_muscle_fiber | 0.98569398 |
| 79 | MP0002066_abnormal_motor_capabilities/c | 0.97755871 |
| 80 | MP0002736_abnormal_nociception_after | 0.96953022 |
| 81 | MP0005375_adipose_tissue_phenotype | 0.95687556 |
| 82 | MP0000747_muscle_weakness | 0.95535604 |
| 83 | MP0003303_peritoneal_inflammation | 0.94973373 |
| 84 | MP0004185_abnormal_adipocyte_glucose | 0.94060419 |
| 85 | MP0010368_abnormal_lymphatic_system | 0.93360677 |
| 86 | MP0008260_abnormal_autophagy | 0.90298844 |
| 87 | MP0000343_altered_response_to | 0.90127288 |
| 88 | MP0003690_abnormal_glial_cell | 0.88900334 |
| 89 | MP0005334_abnormal_fat_pad | 0.88203184 |
| 90 | MP0001501_abnormal_sleep_pattern | 0.87733497 |
| 91 | MP0004085_abnormal_heartbeat | 0.85310140 |
| 92 | MP0004924_abnormal_behavior | 0.83920173 |
| 93 | MP0005386_behavior/neurological_phenoty | 0.83920173 |
| 94 | MP0003186_abnormal_redox_activity | 0.81612038 |
| 95 | MP0001756_abnormal_urination | 0.81083273 |
| 96 | MP0009764_decreased_sensitivity_to | 0.80757707 |
| 97 | MP0009763_increased_sensitivity_to | 0.80632757 |
| 98 | MP0009642_abnormal_blood_homeostasis | 0.80277237 |
| 99 | MP0005058_abnormal_lysosome_morphology | 0.78890894 |
| 100 | MP0002638_abnormal_pupillary_reflex | 0.77621576 |
| 101 | MP0003075_altered_response_to | 0.77472464 |
| 102 | MP0004215_abnormal_myocardial_fiber | 0.76811882 |
| 103 | MP0005636_abnormal_mineral_homeostasis | 0.76424872 |
| 104 | MP0002653_abnormal_ependyma_morphology | 0.76196104 |
| 105 | MP0004043_abnormal_pH_regulation | 0.75358990 |
| 106 | MP0005620_abnormal_muscle_contractility | 0.75124608 |
| 107 | MP0002882_abnormal_neuron_morphology | 0.74016317 |
| 108 | MP0002108_abnormal_muscle_morphology | 0.73379604 |
| 109 | MP0001984_abnormal_olfaction | 0.72541410 |
| 110 | MP0008961_abnormal_basal_metabolism | 0.71335100 |
| 111 | MP0008469_abnormal_protein_level | 0.70148462 |
| 112 | MP0005266_abnormal_metabolism | 0.69734850 |
| 113 | MP0005448_abnormal_energy_balance | 0.69700044 |
| 114 | MP0002557_abnormal_social/conspecific_i | 0.69326409 |
| 115 | MP0006035_abnormal_mitochondrial_morpho | 0.69172461 |
| 116 | MP0009278_abnormal_bone_marrow | 0.69124928 |
| 117 | MP0005647_abnormal_sex_gland | 0.68777924 |
| 118 | MP0000003_abnormal_adipose_tissue | 0.67437341 |
| 119 | MP0003221_abnormal_cardiomyocyte_apopto | 0.66932853 |
| 120 | MP0002254_reproductive_system_inflammat | 0.66860695 |
| 121 | MP0008775_abnormal_heart_ventricle | 0.66453220 |
| 122 | MP0000955_abnormal_spinal_cord | 0.66412793 |
| 123 | MP0003011_delayed_dark_adaptation | 0.66155303 |
| 124 | MP0005167_abnormal_blood-brain_barrier | 0.65439572 |
| 125 | MP0008874_decreased_physiological_sensi | 0.65386232 |
| 126 | MP0002972_abnormal_cardiac_muscle | 0.64989200 |
| 127 | MP0002822_catalepsy | 0.64606948 |
| 128 | MP0005385_cardiovascular_system_phenoty | 0.62124084 |
| 129 | MP0001544_abnormal_cardiovascular_syste | 0.62124084 |
| 130 | MP0010630_abnormal_cardiac_muscle | 0.61879703 |
| 131 | MP0000230_abnormal_systemic_arterial | 0.61821215 |
| 132 | MP0005623_abnormal_meninges_morphology | 0.61043554 |
| 133 | MP0005376_homeostasis/metabolism_phenot | 0.60973851 |
| 134 | MP0009780_abnormal_chondrocyte_physiolo | 0.60418466 |
| 135 | MP0000778_abnormal_nervous_system | 0.60149327 |
| 136 | MP0010234_abnormal_vibrissa_follicle | 0.59315805 |
| 137 | MP0002909_abnormal_adrenal_gland | 0.58976654 |
| 138 | MP0000759_abnormal_skeletal_muscle | 0.56981127 |
| 139 | MP0004147_increased_porphyrin_level | 0.56224176 |
| 140 | MP0009115_abnormal_fat_cell | 0.55656848 |
| 141 | MP0002332_abnormal_exercise_endurance | 0.54699715 |
| 142 | MP0006138_congestive_heart_failure | 0.54135878 |
| 143 | MP0002106_abnormal_muscle_physiology | 0.53577990 |
| 144 | MP0003300_gastrointestinal_ulcer | 0.52440722 |
| 145 | MP0000750_abnormal_muscle_regeneration | 0.51811153 |
| 146 | MP0002136_abnormal_kidney_physiology | 0.51586576 |
| 147 | MP0003137_abnormal_impulse_conducting | 0.51310582 |
| 148 | MP0005166_decreased_susceptibility_to | 0.51163520 |
| 149 | MP0004510_myositis | 0.51077220 |
| 150 | MP0003283_abnormal_digestive_organ | 0.51003411 |
| 151 | MP0004145_abnormal_muscle_electrophysio | 0.50927212 |
| 152 | MP0005084_abnormal_gallbladder_morpholo | 0.49115574 |
| 153 | MP0001661_extended_life_span | 0.48893382 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 8.14365291 |
| 2 | Nemaline bodies (HP:0003798) | 8.04411203 |
| 3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 7.83452448 |
| 4 | Type 1 muscle fiber predominance (HP:0003803) | 6.52901636 |
| 5 | Deep venous thrombosis (HP:0002625) | 6.17232180 |
| 6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.87723413 |
| 7 | Intrahepatic cholestasis (HP:0001406) | 5.65785556 |
| 8 | Xanthomatosis (HP:0000991) | 5.37358110 |
| 9 | Myopathic facies (HP:0002058) | 5.16118277 |
| 10 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.05898949 |
| 11 | Hyperlipoproteinemia (HP:0010980) | 4.64644248 |
| 12 | Complement deficiency (HP:0004431) | 4.61295476 |
| 13 | Prolonged partial thromboplastin time (HP:0003645) | 4.47888606 |
| 14 | Hypobetalipoproteinemia (HP:0003563) | 4.43539346 |
| 15 | Ketosis (HP:0001946) | 4.41882318 |
| 16 | Distal arthrogryposis (HP:0005684) | 4.38199805 |
| 17 | Abnormality of skeletal muscle fiber size (HP:0012084) | 4.25698299 |
| 18 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.24160521 |
| 19 | Hyperammonemia (HP:0001987) | 4.22014791 |
| 20 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.12900583 |
| 21 | EMG: myopathic abnormalities (HP:0003458) | 4.08836435 |
| 22 | Muscle fiber splitting (HP:0003555) | 4.07125669 |
| 23 | Hypoglycemic coma (HP:0001325) | 3.88350682 |
| 24 | Rimmed vacuoles (HP:0003805) | 3.84654471 |
| 25 | Hypoalphalipoproteinemia (HP:0003233) | 3.84206336 |
| 26 | Hyperglycinuria (HP:0003108) | 3.84134793 |
| 27 | Increased variability in muscle fiber diameter (HP:0003557) | 3.83054847 |
| 28 | Hyperglycinemia (HP:0002154) | 3.81332154 |
| 29 | Hypolipoproteinemia (HP:0010981) | 3.80267888 |
| 30 | Ketoacidosis (HP:0001993) | 3.75997413 |
| 31 | Calf muscle hypertrophy (HP:0008981) | 3.69796450 |
| 32 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.67888817 |
| 33 | Abnormality of glycine metabolism (HP:0010895) | 3.67888817 |
| 34 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.67822297 |
| 35 | Epidermoid cyst (HP:0200040) | 3.64456220 |
| 36 | Abnormality of the calf musculature (HP:0001430) | 3.58065228 |
| 37 | Round ear (HP:0100830) | 3.56763171 |
| 38 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.49574492 |
| 39 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.46759003 |
| 40 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.43973122 |
| 41 | Abnormality of the common coagulation pathway (HP:0010990) | 3.42427487 |
| 42 | Ulnar deviation of the wrist (HP:0003049) | 3.42037667 |
| 43 | Joint hemorrhage (HP:0005261) | 3.35160142 |
| 44 | Abnormality of complement system (HP:0005339) | 3.32542988 |
| 45 | Calcaneovalgus deformity (HP:0001848) | 3.27418213 |
| 46 | Muscle stiffness (HP:0003552) | 3.25373120 |
| 47 | Distal lower limb amyotrophy (HP:0008944) | 3.24065686 |
| 48 | Neck muscle weakness (HP:0000467) | 3.23235838 |
| 49 | Subaortic stenosis (HP:0001682) | 3.18241690 |
| 50 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.18241690 |
| 51 | Increased connective tissue (HP:0009025) | 3.13096924 |
| 52 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.10785619 |
| 53 | Prolonged bleeding time (HP:0003010) | 3.10549082 |
| 54 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.10450906 |
| 55 | Gout (HP:0001997) | 3.07597949 |
| 56 | Menorrhagia (HP:0000132) | 3.06973896 |
| 57 | Distal lower limb muscle weakness (HP:0009053) | 3.06279843 |
| 58 | Myotonia (HP:0002486) | 3.04817376 |
| 59 | Myoglobinuria (HP:0002913) | 2.98990557 |
| 60 | Abnormality of methionine metabolism (HP:0010901) | 2.93963936 |
| 61 | Deformed tarsal bones (HP:0008119) | 2.93008445 |
| 62 | Difficulty running (HP:0009046) | 2.91550262 |
| 63 | Fat malabsorption (HP:0002630) | 2.90925006 |
| 64 | Frequent falls (HP:0002359) | 2.89883409 |
| 65 | Purpura (HP:0000979) | 2.86779073 |
| 66 | Lower limb amyotrophy (HP:0007210) | 2.86525485 |
| 67 | Skin nodule (HP:0200036) | 2.85395820 |
| 68 | Hypercholesterolemia (HP:0003124) | 2.83164075 |
| 69 | Fetal akinesia sequence (HP:0001989) | 2.82926893 |
| 70 | Abnormality of the intrinsic pathway (HP:0010989) | 2.80229079 |
| 71 | Exercise-induced myalgia (HP:0003738) | 2.74036551 |
| 72 | Abnormality of purine metabolism (HP:0004352) | 2.71410197 |
| 73 | Increased mean platelet volume (HP:0011877) | 2.70998776 |
| 74 | Myocardial infarction (HP:0001658) | 2.68076597 |
| 75 | Cholelithiasis (HP:0001081) | 2.65374982 |
| 76 | Hyperbilirubinemia (HP:0002904) | 2.60325004 |
| 77 | Metabolic acidosis (HP:0001942) | 2.59190025 |
| 78 | Hepatocellular carcinoma (HP:0001402) | 2.58274460 |
| 79 | Abnormal gallbladder morphology (HP:0012437) | 2.57564719 |
| 80 | Delayed CNS myelination (HP:0002188) | 2.56582384 |
| 81 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.56523765 |
| 82 | Dicarboxylic aciduria (HP:0003215) | 2.56523765 |
| 83 | Spinal rigidity (HP:0003306) | 2.56350680 |
| 84 | Abnormality of nucleobase metabolism (HP:0010932) | 2.54950909 |
| 85 | Systemic lupus erythematosus (HP:0002725) | 2.54794847 |
| 86 | Difficulty climbing stairs (HP:0003551) | 2.53572747 |
| 87 | Late onset (HP:0003584) | 2.52423860 |
| 88 | EMG: neuropathic changes (HP:0003445) | 2.51247041 |
| 89 | Petechiae (HP:0000967) | 2.49404418 |
| 90 | Bundle branch block (HP:0011710) | 2.48438932 |
| 91 | Ankle clonus (HP:0011448) | 2.46936725 |
| 92 | Abnormal platelet volume (HP:0011876) | 2.46684345 |
| 93 | Abnormality of serum amino acid levels (HP:0003112) | 2.42379921 |
| 94 | Malignant hyperthermia (HP:0002047) | 2.41211431 |
| 95 | Conjugated hyperbilirubinemia (HP:0002908) | 2.40802431 |
| 96 | Generalized muscle weakness (HP:0003324) | 2.36682180 |
| 97 | Slender build (HP:0001533) | 2.36019779 |
| 98 | Neonatal onset (HP:0003623) | 2.35995417 |
| 99 | Exercise-induced muscle cramps (HP:0003710) | 2.35751858 |
| 100 | Focal motor seizures (HP:0011153) | 2.35427616 |
| 101 | Myokymia (HP:0002411) | 2.34635841 |
| 102 | Absent phalangeal crease (HP:0006109) | 2.34455713 |
| 103 | Abnormality of the foot musculature (HP:0001436) | 2.33533142 |
| 104 | Abnormality of the Achilles tendon (HP:0005109) | 2.30545988 |
| 105 | Paralysis (HP:0003470) | 2.29375958 |
| 106 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.28599269 |
| 107 | Areflexia of lower limbs (HP:0002522) | 2.28194673 |
| 108 | Foot dorsiflexor weakness (HP:0009027) | 2.27099104 |
| 109 | Spontaneous abortion (HP:0005268) | 2.23122511 |
| 110 | Ragged-red muscle fibers (HP:0003200) | 2.23023003 |
| 111 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.22032334 |
| 112 | Limb dystonia (HP:0002451) | 2.21981127 |
| 113 | Bulbar palsy (HP:0001283) | 2.21841969 |
| 114 | Weak cry (HP:0001612) | 2.21610983 |
| 115 | Lethargy (HP:0001254) | 2.21323440 |
| 116 | Generalized aminoaciduria (HP:0002909) | 2.21151362 |
| 117 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.21131949 |
| 118 | Scapular winging (HP:0003691) | 2.18049899 |
| 119 | Spastic diplegia (HP:0001264) | 2.17210325 |
| 120 | Abnormal cartilage morphology (HP:0002763) | 2.16786641 |
| 121 | Hypoglycemic seizures (HP:0002173) | 2.16395068 |
| 122 | Rhabdomyolysis (HP:0003201) | 2.16075453 |
| 123 | Waddling gait (HP:0002515) | 2.15994216 |
| 124 | Cholecystitis (HP:0001082) | 2.15768552 |
| 125 | Abnormal gallbladder physiology (HP:0012438) | 2.15768552 |
| 126 | Mitral stenosis (HP:0001718) | 2.14617754 |
| 127 | Sudden death (HP:0001699) | 2.13171036 |
| 128 | Hydroxyprolinuria (HP:0003080) | 2.11806659 |
| 129 | Abnormality of proline metabolism (HP:0010907) | 2.11806659 |
| 130 | Limb-girdle muscle atrophy (HP:0003797) | 2.10868855 |
| 131 | Visual hallucinations (HP:0002367) | 2.10365429 |
| 132 | Glomerulonephritis (HP:0000099) | 2.09638590 |
| 133 | Abnormality of binocular vision (HP:0011514) | 2.08866930 |
| 134 | Diplopia (HP:0000651) | 2.08866930 |
| 135 | Dilated cardiomyopathy (HP:0001644) | 2.08516394 |
| 136 | Hyperuricemia (HP:0002149) | 2.07745372 |
| 137 | Increased purine levels (HP:0004368) | 2.07745372 |
| 138 | Gowers sign (HP:0003391) | 2.07224274 |
| 139 | Hyporeflexia of lower limbs (HP:0002600) | 2.07200553 |
| 140 | Cerebral edema (HP:0002181) | 2.06760354 |
| 141 | Esophageal varix (HP:0002040) | 2.06700710 |
| 142 | Epistaxis (HP:0000421) | 2.05055319 |
| 143 | Sensorimotor neuropathy (HP:0007141) | 2.02716715 |
| 144 | Steatorrhea (HP:0002570) | 2.02697227 |
| 145 | Hyperglycemia (HP:0003074) | 2.02397226 |
| 146 | Abnormality of the calcaneus (HP:0008364) | 2.01841156 |
| 147 | Abnormality of the gallbladder (HP:0005264) | 1.97384461 |
| 148 | Amyloidosis (HP:0011034) | 1.96824541 |
| 149 | Vomiting (HP:0002013) | 1.95242701 |
| 150 | Vascular calcification (HP:0004934) | 1.95123565 |
| 151 | Hypochromic microcytic anemia (HP:0004840) | 1.93069130 |
| 152 | Death in childhood (HP:0003819) | 1.92252612 |
| 153 | Asymmetric septal hypertrophy (HP:0001670) | 1.91594360 |
| 154 | Shoulder girdle muscle weakness (HP:0003547) | 1.89741660 |
| 155 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.89314998 |
| 156 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.89314998 |
| 157 | * Irritability (HP:0000737) | 1.87684535 |
| 158 | Pancreatitis (HP:0001733) | 1.87094295 |
| 159 | Abnormal atrioventricular conduction (HP:0005150) | 1.85875964 |
| 160 | Atrioventricular block (HP:0001678) | 1.85792197 |
| 161 | Increased intramyocellular lipid droplets (HP:0012240) | 1.84881991 |
| 162 | Hemorrhage of the eye (HP:0011885) | 1.84668955 |
| 163 | Limb-girdle muscle weakness (HP:0003325) | 1.83451138 |
| 164 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.82769046 |
| 165 | Malnutrition (HP:0004395) | 1.82415147 |
| 166 | Reticulocytosis (HP:0001923) | 1.81841816 |
| 167 | Status epilepticus (HP:0002133) | 1.80918838 |
| 168 | Steppage gait (HP:0003376) | 1.80789285 |
| 169 | Abnormal finger flexion creases (HP:0006143) | 1.80561168 |
| 170 | Turricephaly (HP:0000262) | 1.80450259 |
| 171 | Heart block (HP:0012722) | 1.79875578 |
| 172 | Lymphangioma (HP:0100764) | 1.78457433 |
| 173 | Polycythemia (HP:0001901) | 1.78337743 |
| 174 | Right ventricular cardiomyopathy (HP:0011663) | 1.77913340 |
| 175 | Cardiovascular calcification (HP:0011915) | 1.77905340 |
| 176 | Lipoatrophy (HP:0100578) | 1.76059912 |
| 177 | Nephritis (HP:0000123) | 1.75174099 |
| 178 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.74891420 |
| 179 | Increased muscle lipid content (HP:0009058) | 1.74644036 |
| 180 | Failure to thrive in infancy (HP:0001531) | 1.73197434 |
| 181 | Achilles tendon contracture (HP:0001771) | 1.72609346 |
| 182 | Pelvic girdle muscle weakness (HP:0003749) | 1.72518035 |
| 183 | Abnormality of the neuromuscular junction (HP:0003398) | 1.71445953 |
| 184 | Fatigable weakness (HP:0003473) | 1.71445953 |
| 185 | Atonic seizures (HP:0010819) | 1.71322991 |
| 186 | Generalized tonic-clonic seizures (HP:0002069) | 1.70381479 |
| 187 | Spastic gait (HP:0002064) | 1.70176328 |
| 188 | Abnormal pupillary function (HP:0007686) | 1.69006133 |
| 189 | Rapidly progressive (HP:0003678) | 1.68036019 |
| 190 | Exercise intolerance (HP:0003546) | 1.67129346 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.51676560 |
| 2 | TRIB3 | 4.07687520 |
| 3 | TAOK3 | 3.68134816 |
| 4 | ERN1 | 3.16396896 |
| 5 | PKN2 | 3.07692626 |
| 6 | SIK1 | 2.95166167 |
| 7 | MARK1 | 2.86793593 |
| 8 | FGFR4 | 2.49516696 |
| 9 | TTN | 2.47642771 |
| 10 | RIPK1 | 2.34265178 |
| 11 | PINK1 | 2.04533039 |
| 12 | PHKG2 | 1.86216955 |
| 13 | PHKG1 | 1.86216955 |
| 14 | MAP2K4 | 1.78488653 |
| 15 | INSRR | 1.67802514 |
| 16 | CCNB1 | 1.66500766 |
| 17 | PTK6 | 1.57898332 |
| 18 | TESK1 | 1.55754749 |
| 19 | MAP2K7 | 1.52087055 |
| 20 | MAP3K4 | 1.48047363 |
| 21 | MAP3K7 | 1.47712889 |
| 22 | KSR2 | 1.42755208 |
| 23 | OBSCN | 1.41308129 |
| 24 | DAPK2 | 1.40363382 |
| 25 | TESK2 | 1.35702891 |
| 26 | TAOK2 | 1.33802086 |
| 27 | LMTK2 | 1.32744501 |
| 28 | TAOK1 | 1.32421283 |
| 29 | GRK5 | 1.29451272 |
| 30 | PRPF4B | 1.25878599 |
| 31 | MOS | 1.23643416 |
| 32 | ICK | 1.22060445 |
| 33 | ARAF | 1.21090412 |
| 34 | RIPK4 | 1.20860066 |
| 35 | NEK1 | 1.20412664 |
| 36 | MAP3K9 | 1.19271028 |
| 37 | PDK4 | 1.19105187 |
| 38 | PDK3 | 1.19105187 |
| 39 | CDK19 | 1.15873873 |
| 40 | ERBB4 | 1.13167125 |
| 41 | EPHB1 | 1.12411335 |
| 42 | NTRK3 | 1.10699621 |
| 43 | MAPK11 | 1.10655861 |
| 44 | PIM2 | 1.10443728 |
| 45 | LIMK1 | 1.08084396 |
| 46 | CAMK2B | 1.06498978 |
| 47 | MINK1 | 1.06028396 |
| 48 | MAPKAPK3 | 1.04866437 |
| 49 | MAP3K6 | 1.02818543 |
| 50 | NTRK2 | 1.02352475 |
| 51 | MST1R | 1.02201740 |
| 52 | PDGFRA | 1.01808721 |
| 53 | JAK1 | 1.00411468 |
| 54 | UHMK1 | 1.00305524 |
| 55 | CDK14 | 0.99990454 |
| 56 | MAP3K10 | 0.99000966 |
| 57 | TYK2 | 0.98576330 |
| 58 | MARK2 | 0.97692092 |
| 59 | JAK2 | 0.97623650 |
| 60 | PRKAA2 | 0.96550259 |
| 61 | EPHB2 | 0.95923059 |
| 62 | PIK3CG | 0.95072873 |
| 63 | MAP3K13 | 0.94621856 |
| 64 | FLT3 | 0.93594823 |
| 65 | PDPK1 | 0.93002082 |
| 66 | MAP2K3 | 0.92566783 |
| 67 | MAP4K2 | 0.92326404 |
| 68 | MAPK12 | 0.91670862 |
| 69 | RET | 0.90860674 |
| 70 | CAMK1 | 0.90303802 |
| 71 | MUSK | 0.90228600 |
| 72 | ABL2 | 0.89318045 |
| 73 | BMX | 0.88563430 |
| 74 | MAPK13 | 0.86772861 |
| 75 | PLK2 | 0.86509901 |
| 76 | CDK15 | 0.86217013 |
| 77 | CAMK1D | 0.85618522 |
| 78 | CDK11A | 0.85370013 |
| 79 | PRKAA1 | 0.85168299 |
| 80 | PAK6 | 0.85120886 |
| 81 | PAK3 | 0.83279959 |
| 82 | CSNK1G3 | 0.82591865 |
| 83 | LATS2 | 0.82585385 |
| 84 | CDK5 | 0.81043503 |
| 85 | CAMK2A | 0.80756237 |
| 86 | CDK18 | 0.80205907 |
| 87 | STK38 | 0.78682447 |
| 88 | TBK1 | 0.77985860 |
| 89 | CAMK2D | 0.76839422 |
| 90 | LATS1 | 0.76348459 |
| 91 | CAMKK1 | 0.75399616 |
| 92 | NEK9 | 0.71160673 |
| 93 | PDK1 | 0.70626674 |
| 94 | EPHA4 | 0.68806991 |
| 95 | PDK2 | 0.67732488 |
| 96 | PRKD3 | 0.67500047 |
| 97 | PTK2 | 0.67219101 |
| 98 | PRKD1 | 0.66481087 |
| 99 | CAMK1G | 0.66371118 |
| 100 | DMPK | 0.65153419 |
| 101 | ERBB2 | 0.64906917 |
| 102 | MYLK | 0.64899496 |
| 103 | CSNK1G2 | 0.63609451 |
| 104 | PRKCH | 0.63330290 |
| 105 | MAP3K1 | 0.62765522 |
| 106 | DDR2 | 0.62545256 |
| 107 | DAPK1 | 0.62333601 |
| 108 | MAP3K11 | 0.62255460 |
| 109 | PRKCZ | 0.61445032 |
| 110 | PIK3CA | 0.61055840 |
| 111 | SGK3 | 0.60517341 |
| 112 | PRKACG | 0.60153654 |
| 113 | MAP2K1 | 0.59772082 |
| 114 | NTRK1 | 0.59450891 |
| 115 | SYK | 0.56677086 |
| 116 | PKN1 | 0.56406424 |
| 117 | FGFR2 | 0.56192951 |
| 118 | CAMK2G | 0.55468488 |
| 119 | PAK1 | 0.55396071 |
| 120 | MTOR | 0.54066200 |
| 121 | DYRK2 | 0.51049001 |
| 122 | SIK2 | 0.50368716 |
| 123 | GRK6 | 0.50234007 |
| 124 | MAP3K2 | 0.50180251 |
| 125 | WNK4 | 0.49429711 |
| 126 | MAP3K5 | 0.48649350 |
| 127 | GSK3A | 0.48388469 |
| 128 | IRAK2 | 0.48230767 |
| 129 | TYRO3 | 0.47873174 |
| 130 | DAPK3 | 0.46751898 |
| 131 | STK11 | 0.46627494 |
| 132 | PRKCG | 0.46091134 |
| 133 | PRKG1 | 0.45884395 |
| 134 | DYRK1B | 0.45712009 |
| 135 | CAMK4 | 0.45502195 |
| 136 | PTK2B | 0.43058254 |
| 137 | MAPK7 | 0.42105806 |
| 138 | EEF2K | 0.41965551 |
| 139 | BTK | 0.41658005 |
| 140 | MET | 0.40593807 |
| 141 | MAP2K2 | 0.39972626 |
| 142 | MAPKAPK5 | 0.39474918 |
| 143 | MAP2K6 | 0.39222431 |
| 144 | MAPK10 | 0.38967932 |
| 145 | ROCK1 | 0.38919677 |
| 146 | AKT2 | 0.37909529 |
| 147 | TIE1 | 0.37741637 |
| 148 | TGFBR2 | 0.36382380 |
| 149 | ZAP70 | 0.35988879 |
| 150 | MAPK4 | 0.35979720 |
| 151 | KDR | 0.35059605 |
| 152 | TNK2 | 0.34708484 |
| 153 | RPS6KA3 | 0.34567210 |
| 154 | CSK | 0.34338498 |
| 155 | FGFR3 | 0.33290581 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.02501913 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.99851071 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.69204306 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.09861689 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.88226531 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.76809545 |
| 7 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.72303913 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.71186491 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.64464832 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.56751022 |
| 11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.38015136 |
| 12 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.34581697 |
| 13 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.34399357 |
| 14 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.31908975 |
| 15 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.30476439 |
| 16 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.10132550 |
| 17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.07024257 |
| 18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.04331691 |
| 19 | Circadian entrainment_Homo sapiens_hsa04713 | 1.92376679 |
| 20 | Peroxisome_Homo sapiens_hsa04146 | 1.88620543 |
| 21 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.84643793 |
| 22 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.80693690 |
| 23 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.77139547 |
| 24 | Platelet activation_Homo sapiens_hsa04611 | 1.76739134 |
| 25 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.73834325 |
| 26 | Nicotine addiction_Homo sapiens_hsa05033 | 1.73153771 |
| 27 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.65771310 |
| 28 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.65055204 |
| 29 | Long-term potentiation_Homo sapiens_hsa04720 | 1.64902022 |
| 30 | Bile secretion_Homo sapiens_hsa04976 | 1.63317316 |
| 31 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.61431409 |
| 32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.61022661 |
| 33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.59675584 |
| 34 | Morphine addiction_Homo sapiens_hsa05032 | 1.58645035 |
| 35 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.56312942 |
| 36 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.53499212 |
| 37 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.51724482 |
| 38 | Carbon metabolism_Homo sapiens_hsa01200 | 1.48435449 |
| 39 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.48316573 |
| 40 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.48235487 |
| 41 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.40367735 |
| 42 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.39139469 |
| 43 | Cocaine addiction_Homo sapiens_hsa05030 | 1.38613742 |
| 44 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.37743282 |
| 45 | Gap junction_Homo sapiens_hsa04540 | 1.37446167 |
| 46 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.36141196 |
| 47 | Histidine metabolism_Homo sapiens_hsa00340 | 1.34133577 |
| 48 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.33299759 |
| 49 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.29958741 |
| 50 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.29607270 |
| 51 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.29524268 |
| 52 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.29099940 |
| 53 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.26528364 |
| 54 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.21123852 |
| 55 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.20634004 |
| 56 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.19780817 |
| 57 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.14881617 |
| 58 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.13229855 |
| 59 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.12511732 |
| 60 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.12160671 |
| 61 | Salivary secretion_Homo sapiens_hsa04970 | 1.11175812 |
| 62 | Circadian rhythm_Homo sapiens_hsa04710 | 1.11078300 |
| 63 | Retinol metabolism_Homo sapiens_hsa00830 | 1.10738712 |
| 64 | Alcoholism_Homo sapiens_hsa05034 | 1.09173812 |
| 65 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.08879552 |
| 66 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.07290467 |
| 67 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.06496657 |
| 68 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.05065112 |
| 69 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.04591627 |
| 70 | Renin secretion_Homo sapiens_hsa04924 | 1.03352641 |
| 71 | ABC transporters_Homo sapiens_hsa02010 | 1.02117239 |
| 72 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.01921162 |
| 73 | Parkinsons disease_Homo sapiens_hsa05012 | 0.99522820 |
| 74 | Long-term depression_Homo sapiens_hsa04730 | 0.99043037 |
| 75 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.98550974 |
| 76 | Lysine degradation_Homo sapiens_hsa00310 | 0.94836626 |
| 77 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.93795127 |
| 78 | Insulin secretion_Homo sapiens_hsa04911 | 0.93126075 |
| 79 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.91255509 |
| 80 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.91193196 |
| 81 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.88999064 |
| 82 | Glioma_Homo sapiens_hsa05214 | 0.87331981 |
| 83 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.86594484 |
| 84 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.86557565 |
| 85 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.84057873 |
| 86 | Olfactory transduction_Homo sapiens_hsa04740 | 0.83292908 |
| 87 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.81995896 |
| 88 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.80740548 |
| 89 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.80725222 |
| 90 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.78072993 |
| 91 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.77963260 |
| 92 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.77011295 |
| 93 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.75732546 |
| 94 | Endocytosis_Homo sapiens_hsa04144 | 0.75393890 |
| 95 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.75086749 |
| 96 | Alzheimers disease_Homo sapiens_hsa05010 | 0.73857847 |
| 97 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.73766924 |
| 98 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.72529864 |
| 99 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.72231463 |
| 100 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.72065037 |
| 101 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.70205871 |
| 102 | Focal adhesion_Homo sapiens_hsa04510 | 0.68705015 |
| 103 | Sulfur relay system_Homo sapiens_hsa04122 | 0.68490438 |
| 104 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.67790972 |
| 105 | Insulin resistance_Homo sapiens_hsa04931 | 0.66523962 |
| 106 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.66058686 |
| 107 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.65545115 |
| 108 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.64716969 |
| 109 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.63211221 |
| 110 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.58941587 |
| 111 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.57869797 |
| 112 | Prion diseases_Homo sapiens_hsa05020 | 0.57023821 |
| 113 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.56585857 |
| 114 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.52015909 |
| 115 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.50210173 |
| 116 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.47352518 |
| 117 | Axon guidance_Homo sapiens_hsa04360 | 0.46520619 |
| 118 | Shigellosis_Homo sapiens_hsa05131 | 0.45305546 |
| 119 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.44966822 |
| 120 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.43453091 |
| 121 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.42886986 |
| 122 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.42299926 |
| 123 | Salmonella infection_Homo sapiens_hsa05132 | 0.41877082 |
| 124 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.41812087 |
| 125 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.41388867 |
| 126 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.41033476 |
| 127 | * Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.39830748 |
| 128 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.38668160 |
| 129 | Melanogenesis_Homo sapiens_hsa04916 | 0.38120985 |
| 130 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.35960262 |
| 131 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.35708774 |
| 132 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.35100530 |
| 133 | Galactose metabolism_Homo sapiens_hsa00052 | 0.32140641 |
| 134 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.31807116 |
| 135 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.31227761 |
| 136 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.30711665 |
| 137 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.27575983 |
| 138 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.21677283 |
| 139 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.18612952 |
| 140 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.18026031 |
| 141 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.16949789 |
| 142 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.16375614 |
| 143 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15658580 |
| 144 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.14294535 |
| 145 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.14288435 |
| 146 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.13563949 |
| 147 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.12934560 |
| 148 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.12441888 |
| 149 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.10371469 |
| 150 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.09165017 |
| 151 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.07767963 |
| 152 | Amoebiasis_Homo sapiens_hsa05146 | 0.06176292 |
| 153 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.05111026 |
| 154 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.01327150 |
| 155 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.00738557 |
| 156 | GABAergic synapse_Homo sapiens_hsa04727 | -0.0855814 |
| 157 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0580521 |
| 158 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0465568 |
| 159 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | -0.0389824 |
| 160 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | -0.0027275 |
| 161 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | -0.0014791 |

